Patent Application: Method for Acute Respiratory Distress Syndrome Treatment

ChangeBridge: Patent Apps - Peptides (C07K)

Detected March 26th, 2026

Summary

The USPTO has published a new patent application (US20260085098A1) from Revolo Biotherapeutics Limited for a method to treat acute respiratory distress syndrome. The application details a treatment method involving the administration of a specific peptide molecule during or in response to a relapse to induce remission.

View original document View source feed page

What changed

This document is a publication of a patent application filed by Revolo Biotherapeutics Limited, identified as US20260085098A1. The application describes a method for the acute treatment of acute respiratory distress syndrome (ARDS) by administering a specific peptide molecule during a relapse to induce remission. The filing date was May 13, 2025, and the publication date is March 26, 2026.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signifies potential future intellectual property rights and may influence research and development in ARDS treatments. Companies operating in the pharmaceutical and biotechnology sectors, particularly those involved in peptide therapeutics or ARDS treatment, should be aware of this filing for competitive intelligence and potential licensing or collaboration opportunities.

Source document (simplified)

← USPTO Patent Applications

METHOD FOR THE TREATMENT OF AN ACUTE RESPIRATORY DISTRESS SYNDROME

Application US20260085098A1 Kind: A1 Mar 26, 2026

Assignee

Revolo Biotherapeutics Limited

Inventors

Andrew Lightfoot, Nicola Cooper, Donata Federici Canova, Roly Foulkes

Abstract

The present invention relates to a method for the acute treatment of a relapsing-remitting condition, the method comprising the step of administering to a subject in need thereof one or more doses of an effective amount of a peptide molecule as defined in claim 1 in response to or during a relapse, wherein the method causes remission of the condition.